According to Renalytix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 19.5669. At the end of 2023 the company had a P/S ratio of 8.23.
Year | P/S ratio | Change |
---|---|---|
2023 | 8.23 | -52.16% |
2022 | 17.2 | -93.12% |
2021 | 250 | -79.08% |
2020 | > 1000 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Anaplan
PLAN | N/A | N/A | ๐บ๐ธ USA |